Abacavir: pretreatment screening: warning. Encouraging method but uncertainties remain.
HIV-infected patients carrying the HLA-B*5701 allele are at a significantly increased risk of developing hypersensitivity reactions to abacavir. It is therefore a good idea to identify these patients before initiating treatment. But even when patients test negative, hypersensitivity reactions are possible.